CURRENT NEWS

• 27.01.2021
  Introduction of Salmeterol / Fluticason Neutec Inhalation Powder
• 27.01.2021
  Introduction Tramadol HCI Prolepha Retard 100Mg
• 27.01.2021
  Security the Biggest Challenge in Domain Management as 2020 Recorded Rise in Domain-Related Cyber Attacks, Says New Clarivate Report
• 27.01.2021
  Withdrawal of Complaint Regarding Eldecalcitol Patent by Chugai Pharmaceutical Co., Ltd
• 26.01.2021
  Nelipak Laboratory Services Completed Validation of New Climatic Conditioning Chamber
• 26.01.2021
  Predictive Oncology Announces Closing of $4.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
• 26.01.2021
  Personalis Announces Pricing of Public Offering of Common Stock
• 26.01.2021
  Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC for Treatment of ICU COVID-19 Patients
• 26.01.2021
  Samsung Biologics, National OncoVenture, and Eutilex Obtain IND Approval From FDA
• 26.01.2021
  Personalis Announces Launch of Public Offering of Common Stock
• 26.01.2021
  PerkinElmer Launches Industry-First GPCR TR-FRET Binding Assay and Beta-Arrestin Kits to Help Advance Therapeutics Discovery
• 26.01.2021
  DuPont Launches SYNERXIA Gemstone Collection of New High-Performance Yeasts for U.S. Ethanol Market
• 26.01.2021
  Aphena's 500,000-Square-Foot Expansion in Tennessee Nears Completion
• 26.01.2021
  New Data Show Treatment With Etesevimab (JS016) and Bamlanivimab Together Reduced Risk of COVID-19 Hospitalizations and Death by 70 Percent
• 26.01.2021
  Care Access Research Collaborates With AstraZeneca on Phase III Clinical Trial for COVID-19 Long-Acting Antibody Combination
• 26.01.2021
  Novel SARS CoV-2 Saliva Collection Devices Address COVID-19 Testing Challenges, Improving Lab Efficiency and PCR Test Performance
• 26.01.2021
  HCA Healthcare Uses Its COVID-19 Registry by Forming Consortium With AHRQ and Research Institutions to Accelerate COVID-19 Research
• 26.01.2021
  X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service Range
• 26.01.2021
  RECORDATI RARE DISEASES: CARBAGLU (Carglumic Acid) Tablets 200mg Receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated With Propionic Acidemia and Methylmalonic Acidemia
• 26.01.2021
  Integrity Laboratories Launches Novel Quantification Tool for COVID-19 Providers

Records per page:

Page

Total: 24267 records.